XML 17 R6.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated Statements of Stockholders’ Equity (Deficit) (Unaudited) - USD ($)
Common Stock
Stock to be issued
Stock Subscription Receivable
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Income
Treasury Stock
Noncontrolling Interest
Total
Balance at Dec. 31, 2022 $ 3,286 $ (1,354,440) $ 67,937,050 $ (54,904,439) $ 517,128 $ (9,100,000) $ 137,554 $ 3,236,139
Balance (in Shares) at Dec. 31, 2022 3,286,190           (27,535)    
Issuance of subsidiaries' common shares for consulting service $ 22 140,727 140,749
Issuance of subsidiaries' common shares for consulting service (in Shares) 22,341                
Issuance of pre-funded warrant 1,729,028 1,729,028
Stock-based compensation 451,480 451,480
Net loss for the period (4,087,206) (125,249) (4,212,455)
Cumulative transaction adjustments 17,077 17,077
Balance at Jun. 30, 2023 $ 3,308 (902,960) 69,806,805 (58,991,645) 534,205 $ (9,100,000) 12,305 1,362,018
Balance (in Shares) at Jun. 30, 2023 3,308,531           (27,535)    
Balance at Dec. 31, 2022 $ 3,286 (1,354,440) 67,937,050 (54,904,439) 517,128 $ (9,100,000) 137,554 3,236,139
Balance (in Shares) at Dec. 31, 2022 3,286,190           (27,535)    
Net loss for the period                 (7,580,535)
Balance at Sep. 30, 2023 $ 4,823 (677,220) 80,662,290 (62,309,161) 519,123 $ (9,100,000) (38,259) 9,061,596
Balance (in Shares) at Sep. 30, 2023 4,823,043           (27,535)    
Balance at Jun. 30, 2023 $ 3,308 (902,960) 69,806,805 (58,991,645) 534,205 $ (9,100,000) 12,305 1,362,018
Balance (in Shares) at Jun. 30, 2023 3,308,531           (27,535)    
Issuance of common stock for cash $ 300 1,049,700 1,050,000
Issuance of common stock for cash (in Shares) 300,000                
Issuance of common stock for consulting services $ 30 591,970 592,000
Issuance of common stock for consulting services (in Shares) 29,600                
Issuance of common stock for acquiring of property $ 370 7,399,630 7,400,000
Issuance of common stock for acquiring of property (in Shares) 370,000                
Issuance of common stock upon exercise of convertible notes $ 615 1,814,185 1,814,800
Issuance of common stock upon exercise of convertible notes (in Shares) 614,912                
Exercise of pre-funded warrant $ 200 (700,000) (699,800)
Exercise of pre-funded warrant (in Shares) 200,000                
Issuance of pre-funded warrant 700,000 700,000
Stock-based compensation 225,740   225,740
Net loss for the period   (3,317,516) (50,564) (3,368,080)
Cumulative transaction adjustments   (15,082) (15,082)
Balance at Sep. 30, 2023 $ 4,823 (677,220) 80,662,290 (62,309,161) 519,123 $ (9,100,000) (38,259) 9,061,596
Balance (in Shares) at Sep. 30, 2023 4,823,043           (27,535)    
Balance at Dec. 31, 2023 $ 7,940 (451,480) 82,636,966 (65,420,095) 516,387 $ (8,901,668) (257,078) 8,130,972
Balance (in Shares) at Dec. 31, 2023 7,940,298           (27,535)    
Issuance of common stock upon exercise of convertible notes $ 905 810,269 811,174
Issuance of common stock upon exercise of convertible notes (in Shares) 905,303                
Issuance of subsidiaries' common shares for consulting service 383,500 383,500
Issuance of pre-funded warrant 394,071 394,071
Repurchase of common stock $ 703 $ (703)
Repurchase of common stock (in Shares) 703,496           (703,496)    
Stock-based compensation $ 1,504 451,480 2,121,252 2,574,236
Stock-based compensation (in Shares) 1,502,726                
Exercise of common stock warrants $ 1,000 736,500 737,500
Exercise of common stock warrants (in Shares) 1,000,000                
Stock to be issued 31,040 100,000 131,040
Net loss for the period (4,945,621) (308,087) (5,253,708)
Cumulative transaction adjustments (80,495) (80,495)
Balance at Jun. 30, 2024 $ 12,052 31,040   87,082,558 (70,365,716) 435,892 $ (8,902,371) (465,165) 7,828,290
Balance (in Shares) at Jun. 30, 2024 12,051,823           (731,031)    
Balance at Dec. 31, 2023 $ 7,940 (451,480) 82,636,966 (65,420,095) 516,387 $ (8,901,668) (257,078) 8,130,972
Balance (in Shares) at Dec. 31, 2023 7,940,298           (27,535)    
Net loss for the period                 (5,387,980)
Balance at Sep. 30, 2024 $ 12,712 31,040   87,308,080 (70,552,277) 461,282 $ (8,902,371) (379,144) 7,979,322
Balance (in Shares) at Sep. 30, 2024 12,711,345           (731,031)    
Balance at Jun. 30, 2024 $ 12,052 31,040   87,082,558 (70,365,716) 435,892 $ (8,902,371) (465,165) 7,828,290
Balance (in Shares) at Jun. 30, 2024 12,051,823           (731,031)    
Issuance of common stock upon exercise of convertible notes $ 400     34,140         34,540
Issuance of common stock upon exercise of convertible notes (in Shares) 400,000                
Stock-based compensation $ 260 191,382 191,642
Stock-based compensation (in Shares) 259,522                
Stock to be issued               33,732 33,732
Net loss for the period         (186,561)     52,289 (134,272)
Cumulative transaction adjustments           25,390     25,390
Balance at Sep. 30, 2024 $ 12,712 $ 31,040   $ 87,308,080 $ (70,552,277) $ 461,282 $ (8,902,371) $ (379,144) $ 7,979,322
Balance (in Shares) at Sep. 30, 2024 12,711,345           (731,031)